LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer
ConclusionsLJM716 was well tolerated in Japanese patients, and a degree of tumor shrinkage was observed.Clinical trial informationClinicalTrials.gov NCT01911936.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Drugs & Pharmacology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Head and Neck Cancer | HER2 | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology